V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010598 | 190007137 | 1.81 | 74 | Palliative (P) | 2016-10-23 | 2018-04-10 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 101068976 |
| 190010604 | 190007138 | 1.77 | 77.2 | Palliative (P) | 2017-08-21 | 2017-08-26 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101695167 |
| 190010618 | 190007139 | 1.6 | 61.3 | Curative (C) | 2019-09-28 | 2019-09-30 | Ixazomib + Lenalidomide | 01 | N | NB HRNBL | 100180550 |
| 190010631 | 190007141 | 0 | 51.1 | Palliative (P) | 2021-02-25 | 2021-03-19 | METHOTREXATE | 02 | Y | METHOTREXATE | 101376355 |
| 190010645 | 190007142 | 0 | 62.2 | Neo-adjuvant (N) | 2021-09-12 | 2022-01-28 | OST Mifamurtide | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 101482072 |
| 190010650 | 190007143 | 1.64 | null | Neo-adjuvant (N) | 2017-11-17 | 2018-05-04 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100561190 |
| 190010672 | 190007144 | 1.47 | 83 | 03 | 2016-10-31 | 2017-06-07 | Irinotecan + Modified De Gramont | 02 | null | CISPLATIN + FLUOROURACIL | 100847315 |
| 190010677 | 190007145 | 1.77 | 59.7 | Palliative (P) | 2019-04-01 | 2019-04-01 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101071807 |
| 190010681 | 190007146 | 1.73 | 72 | Palliative (P) | 2014-11-10 | 2014-11-16 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101015225 |
| 190010685 | 190007147 | 1.85 | 100.5 | Curative (C) | 2017-04-05 | 2017-04-23 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 101159852 |
| 190010688 | 190007148 | 1.6 | 49.9 | null | 2019-08-27 | 2019-10-09 | EW EuroEwing 2012 Arm B IE | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100330018 |
| 190010689 | 190007149 | 1.53 | 88 | null | 2017-02-04 | 2017-02-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | IFOSFAMIDE | 101803600 |
| 190010710 | 190007150 | 1.66 | 75.5 | Curative (C) | 2022-02-10 | 2022-03-15 | CAPECITABINE + CARBOPLATIN | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101002130 |
| 190010716 | 190007151 | 1.73 | 74.9 | null | 2017-09-02 | 2017-09-06 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 100551431 |
| 190010729 | 190007153 | 1.65 | 150 | Curative (C) | 2017-01-15 | 2017-04-25 | OST Euramos 1 Closed Trial - M | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 100411559 |
| 190010736 | 190007154 | 1.57 | 79.4 | Adjuvant (A) | 2020-05-22 | 2020-06-05 | OST Euramos 1 Closed Trial - A | 01 | N | DOXORUBICIN | 100400244 |
| 190010739 | 190007155 | 1.72 | 90.2 | null | 2017-11-20 | 2018-03-05 | DOCETAXEL + GEMCITABINE | 01 | N | DOCETAXEL + GEMCITABINE | 100569513 |
| 190010741 | 190007156 | 1.72 | 46.4 | Palliative (P) | 2018-11-05 | 2018-11-18 | Cyclophosphamide + Topotecan | 02 | N | MAP + MIFAMURTIDE | 100422291 |
| 190010755 | 190007157 | 1.57 | 46.8 | Palliative (P) | 2017-01-19 | 2017-07-22 | OST Euramos 1 Closed Trial - IE | 02 | N | ETOPOSIDE | 101847115 |
| 190010776 | 190007158 | 0 | 49.8 | Palliative (P) | 2017-11-01 | 2017-11-11 | Dox + HD Mtx (post PAM) | 02 | null | EW EUROEWING 2012 ARM A VIDE | 101547765 |
| 190010800 | 190007159 | 1.81 | 42.8 | Palliative (P) | 2016-12-03 | 2017-06-06 | Oxaliplatin + Modified de Gramont | 02 | N | NB HRNBL-1 BUMEL MAT | 100086834 |
| 190010810 | 190007160 | 1.47 | 36 | Neo-adjuvant (N) | 2018-05-07 | 2018-05-07 | DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 01 | null | EURO-EWING | 100170944 |
| 190010837 | 190007161 | 1.61 | 25.8 | Palliative (P) | 2019-08-15 | 2019-08-16 | ECX | null | null | NOT MATCHED | 101586453 |
| 190010850 | 190007162 | 0 | 60.4 | Palliative (P) | 2018-12-02 | 2018-12-16 | EOX | N | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100033451 |
| 190010853 | 190007163 | 1.71 | 76 | null | 2020-03-21 | 2020-04-18 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100377460 |
| 190010859 | 190007164 | 1.7 | 38.6 | Curative (C) | 2020-05-10 | 2021-01-05 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100146635 |
| 190010862 | 190007165 | 1.6 | 68 | Palliative (P) | 2019-12-09 | 2019-12-25 | CISPLATIN + ETOPOSIDE | 01 | N | MAP | 100176446 |
| 190010868 | 190007166 | 0 | 36.2 | Palliative (P) | null | 2016-09-25 | PACLITAXEL | 01 | null | CARBOPLATIN + ETOPOSIDE | 100206002 |
| 190010881 | 190007167 | 1.6 | 99.75 | Neo-adjuvant (N) | 2020-11-02 | 2020-12-07 | Docetaxel+Gemcitabine (no prior RT) | N | N | DOCETAXEL + GEMCITABINE | 101581794 |
| 190010887 | 190007168 | 1.76 | 78.3 | Curative (C) | 2018-03-15 | 2018-05-10 | Bortezomib + Cyclophos + Dex | 02 | null | STS RHABDO VIT0910 VINC IRINO TEMOZ | 101753075 |
| 190010888 | 190007169 | 1.72 | null | Curative (C) | 2016-12-01 | 2017-05-24 | METHOTREXATE | 02 | N | METHOTREXATE | 101759564 |
| 190010903 | 190007170 | 1.72 | 108.6 | null | 2018-11-13 | 2018-11-13 | OST Euramos 1 Closed Trial - M | null | null | OST M | 101580678 |
| 190010905 | 190007171 | 1.75 | 59 | null | 2016-12-21 | 2017-05-19 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100829799 |
| 190010914 | 190007172 | 1.77 | 49.5 | Curative (C) | 2015-10-20 | 2017-09-16 | OST Euramos 1 Closed Trial - AP | 02 | Y | EW EUROEWING 2012 ARM A VAC | 101520353 |
| 190010928 | 190007173 | 0 | 52 | Palliative (P) | 2021-11-04 | 2021-11-04 | METHOTREXATE | 02 | N | METHOTREXATE | 101391675 |
| 190000680 | 190007174 | 1.7 | 66 | 03 | 2017-02-01 | 2017-02-12 | Folfirinox | 02 | null | STS NON-RHABDO EPSSG 2005 VDCY | 101671483 |
| 190000808 | 190007175 | 1.93 | 97 | Curative (C) | 2020-09-22 | 2020-09-22 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101186648 |
| 190002742 | 190007176 | 1.4 | 80.95 | Curative (C) | 2019-05-11 | 2019-08-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100678585 |
| 190003862 | 190007178 | 1.63 | 64 | Palliative (P) | 2019-05-04 | 2019-12-26 | Cisplatin + Pemetrexed | null | null | MAP | 100394493 |
| 190004163 | 190007179 | 1.46 | 18.9 | null | 2017-03-05 | 2017-03-19 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101625605 |
| 190004933 | 190007181 | 1.56 | 53 | null | 2020-06-28 | 2020-07-01 | null | 02 | N | METHOTREXATE HIGH DOSE | 100493281 |
| 190005536 | 190007182 | 0 | 49.8 | Palliative (P) | 2018-09-10 | 2018-09-10 | ECarboX | 02 | N | DOXORUBICIN + METHOTREXATE | 100026062 |
| 190006089 | 190007183 | null | 143.8 | Disease modification (D) | 2014-04-01 | 2017-12-17 | EVEROLIMUS | 02 | null | EW EUROEWING 2012 ARM A VAI | 100145043 |
| 190006487 | 190007185 | 0 | 38.3 | Palliative (P) | 2017-12-19 | 2017-12-21 | CARBOPLATIN + ETOPOSIDE | 02 | null | ETOPOSIDE | 101098407 |
| 190006530 | 190007186 | 1.77 | 62.1 | null | 2020-11-01 | 2020-11-07 | Docetaxel + nintedanib | 02 | null | LENALIDOMIDE | 100393769 |
| 190006894 | 190007188 | 0 | 58.4 | Palliative (P) | 2019-08-08 | 2020-02-11 | Cyclophosphamide + Vincristine | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101097341 |
| 190007060 | 190007189 | 1.71 | 21.6 | null | 2015-12-16 | 2016-01-09 | VAI (Ifos 3g/m2) | 02 | N | CAV | 100854380 |
| 190007094 | 190007190 | 0 | 28.8 | Curative (C) | 2020-07-11 | 2020-07-13 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 101125341 |
| 190007264 | 190007192 | 0 | 83.5 | null | 2021-02-25 | 2021-02-28 | Cisplatin + Radiotherapy | null | null | EW REL REECUR IFOSFAMIDE | 101834705 |
| 190008183 | 190007194 | 1.88 | 53 | null | 2019-04-29 | 2019-05-08 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101496769 |